JP2021530453A5 - - Google Patents

Info

Publication number
JP2021530453A5
JP2021530453A5 JP2020571855A JP2020571855A JP2021530453A5 JP 2021530453 A5 JP2021530453 A5 JP 2021530453A5 JP 2020571855 A JP2020571855 A JP 2020571855A JP 2020571855 A JP2020571855 A JP 2020571855A JP 2021530453 A5 JP2021530453 A5 JP 2021530453A5
Authority
JP
Japan
Prior art keywords
disease
pharmaceutically acceptable
pharmaceutical composition
stereoisomer
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020571855A
Other languages
English (en)
Japanese (ja)
Other versions
JP7328263B2 (ja
JP2021530453A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/039509 external-priority patent/WO2020006233A1/en
Publication of JP2021530453A publication Critical patent/JP2021530453A/ja
Publication of JP2021530453A5 publication Critical patent/JP2021530453A5/ja
Priority to JP2023126807A priority Critical patent/JP2023145694A/ja
Application granted granted Critical
Publication of JP7328263B2 publication Critical patent/JP7328263B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020571855A 2018-06-29 2019-06-27 免疫調節化合物 Active JP7328263B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023126807A JP2023145694A (ja) 2018-06-29 2023-08-03 免疫調節化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862692176P 2018-06-29 2018-06-29
US62/692,176 2018-06-29
PCT/US2019/039509 WO2020006233A1 (en) 2018-06-29 2019-06-27 Immunomodulatory compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023126807A Division JP2023145694A (ja) 2018-06-29 2023-08-03 免疫調節化合物

Publications (3)

Publication Number Publication Date
JP2021530453A JP2021530453A (ja) 2021-11-11
JP2021530453A5 true JP2021530453A5 (cg-RX-API-DMAC7.html) 2022-07-05
JP7328263B2 JP7328263B2 (ja) 2023-08-16

Family

ID=68987232

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020571855A Active JP7328263B2 (ja) 2018-06-29 2019-06-27 免疫調節化合物
JP2023126807A Pending JP2023145694A (ja) 2018-06-29 2023-08-03 免疫調節化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023126807A Pending JP2023145694A (ja) 2018-06-29 2023-08-03 免疫調節化合物

Country Status (8)

Country Link
US (1) US12234220B2 (cg-RX-API-DMAC7.html)
EP (1) EP3814330A4 (cg-RX-API-DMAC7.html)
JP (2) JP7328263B2 (cg-RX-API-DMAC7.html)
KR (1) KR102834593B1 (cg-RX-API-DMAC7.html)
CN (1) CN113166100A (cg-RX-API-DMAC7.html)
AU (1) AU2019293235B2 (cg-RX-API-DMAC7.html)
CA (1) CA3102212A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020006233A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118108706A (zh) * 2017-09-04 2024-05-31 C4医药公司 戊二酰亚胺
CA3102212A1 (en) * 2018-06-29 2020-01-02 Dana-Farber Cancer Institute, Inc. Immunomodulatory compounds
KR102947433B1 (ko) 2019-04-12 2026-04-06 씨4 테라퓨틱스, 인코포레이티드 이카로스 및 아이올로스의 트리시클릭 분해제
JP7852923B2 (ja) * 2019-11-27 2026-04-28 キャプター セラピューティクス エス.エー. セレブロンに結合するピペリジン-2,6-ジオン誘導体、及びその使用方法
PH12022551482A1 (en) 2019-12-18 2023-11-29 Novartis Ag 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
WO2022255889A1 (en) * 2021-06-01 2022-12-08 Captor Therapeutics S.A. Compounds which bind to cereblon, and use thereof
WO2022254362A1 (en) 2021-06-03 2022-12-08 Novartis Ag 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and medical uses thereof
JP2025531869A (ja) 2022-09-09 2025-09-25 イノヴォ セラピューティクス、インコーポレイテッド CK1αおよびDUAL CK1α/GSPT1分解化合物
CN116655595A (zh) * 2023-06-05 2023-08-29 中国人民解放军军事科学院军事医学研究院 2,6-哌啶二酮衍生物及其制备和用途
AU2024344247A1 (en) 2023-09-19 2026-05-07 Kancure Pte. Ltd. Survivin-targeted compounds
WO2025179161A1 (en) 2024-02-21 2025-08-28 Innovo Therapeutics, Inc. Protein degrading compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698579A (en) * 1993-07-02 1997-12-16 Celgene Corporation Cyclic amides
US7968569B2 (en) 2002-05-17 2011-06-28 Celgene Corporation Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
WO2008007979A1 (en) * 2006-07-12 2008-01-17 Auckland Uniservices Limited (2,6-dioxo-3-piperinyl)amidobenzoic immunomodulatory and anti-cancer derivatives
US9345705B2 (en) 2011-09-15 2016-05-24 Merck Sharp & Dohme Corp. Compositions and methods for treating cancer
CN109153644B (zh) * 2016-03-16 2022-10-21 H·李·莫菲特癌症中心研究有限公司 用以增强效应t细胞功能的针对cereblon的小分子
CN121974842A (zh) * 2016-05-10 2026-05-05 C4医药公司 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
IL319363A (en) * 2017-01-31 2025-05-01 Arvinas Operations Inc Cervalon ligands and bifunctional compounds containing them
CN118108706A (zh) 2017-09-04 2024-05-31 C4医药公司 戊二酰亚胺
US11512080B2 (en) 2018-01-12 2022-11-29 Kymera Therapeutics, Inc. CRBN ligands and uses thereof
CA3102212A1 (en) * 2018-06-29 2020-01-02 Dana-Farber Cancer Institute, Inc. Immunomodulatory compounds

Similar Documents

Publication Publication Date Title
JP2021530451A5 (cg-RX-API-DMAC7.html)
JP2023533938A5 (cg-RX-API-DMAC7.html)
JP2022078315A5 (cg-RX-API-DMAC7.html)
JP2023523130A5 (cg-RX-API-DMAC7.html)
JP2019094340A5 (cg-RX-API-DMAC7.html)
CN113748114A (zh) 一种喹唑啉化合物及其在医药上的应用
JP2023504249A5 (cg-RX-API-DMAC7.html)
JP2016515561A5 (cg-RX-API-DMAC7.html)
JP2020511467A5 (cg-RX-API-DMAC7.html)
JP2020097577A5 (cg-RX-API-DMAC7.html)
RU2017143776A (ru) Пролекарства альвоцидиба, имеющие повышенную биодоступность
JP2017525730A5 (cg-RX-API-DMAC7.html)
JP2022538215A5 (cg-RX-API-DMAC7.html)
JP2015078230A5 (cg-RX-API-DMAC7.html)
JP2017527532A5 (cg-RX-API-DMAC7.html)
JP2021530487A5 (cg-RX-API-DMAC7.html)
JP2021535147A5 (cg-RX-API-DMAC7.html)
CN114072396A (zh) 作为dna-pk抑制剂的喹啉和噌啉衍生物
JP2011527299A5 (cg-RX-API-DMAC7.html)
JP2019520343A5 (cg-RX-API-DMAC7.html)
JP2024538117A5 (cg-RX-API-DMAC7.html)
JP2025060958A5 (cg-RX-API-DMAC7.html)
JP2024512425A5 (cg-RX-API-DMAC7.html)
JP2023538090A5 (cg-RX-API-DMAC7.html)
RU2016136193A (ru) Аминокарбонилкарбаматные соединения